28 results were returned
International law firm Bird & Bird advises Mitsubishi Chemical Advanced Materials (MCAM), a leading global manufacturer of high-performance materials and a business division of Mitsubishi Chemical Corporation, Japan, on ...
If a patentee undertakes actions with respect to a patent of the same patent family (e.g. waiving the parent patent of a divisional patent), this is often negatively characterised as playing the “Divisional Game”. We ...
International law firm Bird & Bird advises Indian vaccine manufacturer Serum Institute of India Pvt. Ltd. on the acquisition of the majority share in German project management service provider Vakzine Projekt Management ...
We were successful in defending our clients in a major Supplementary Protection Certificate (SPC) case.
In the wake of the COVID-19 pandemic the German government has recently passed a “corona crisis package”. The so-called Act for protecting the Population in the Event of an Epidemic Situation of National Importance, the ...
Almost two years ago, the Higher Regional Court Düsseldorf first iterated new liability criteria with respect to Second Medical Use Patents (cf. decision Östrogenblocker of May 5, 2017, docket no. I-2 W 6/17).
On July 25, 2018, the Court of Justice of the European Union (CJEU) handed down its newest SPC decision in re Truvada (C-121/17).